ovynNourish HealthNourish HealthCase Studies
Nourish Health · documentation belongs to usCaptured live · 2026-05-08

Documentation belongs to us.
The prescribing decision belongs to your clinic.

Distributor posture, prescriber-facing. Every execution below was generated against the Nourish brain: Category 1 sourcing, cGMP-certified manufacturing, state-licensed wholesale. No outcome promises. No trade-name comparisons. No patient-facing language. What the rail catches before MLR sees it, the brand brain that anchored the voice, and the chain-of-custody framing the engine learned from the brand's own published copy. Compliance flags are real. The methodology is the same on every execution.

How OVYN™ produces these. the methodology
01
Brief intake
Structured. Brand · audience · channel · asset · claim · constraint. Six fields, one schema.
02
Brand-trained generation
Per-tenant fine-tune on the brand's claims library, voice rules, and approved-content history.
03
Pre-check rail
Eight rule families. Deterministic + LLM-judged. Both must agree to pass.
04
Channel adaptation
One approval, every surface. Email, paid social, LinkedIn, organic. same content, native render.
Nourish Health · Pharma · compounding · wholesale
Case · 01Pharma · compounding · wholesale
Brand-aware visual engine · captured 2026-05-08

Nourish Health

Category 1 bulk substance distribution
Step 1 · The prompt we sent
Real brief sent to POST /api/generate with the brand brain attached.
Audience
Licensed prescribers + clinic operations evaluating compounded partners
Channel
HCP-facing PDF + LinkedIn carousel
Asset
3-frame educational explainer on Category 1 bulk substance sourcing
Primary claim
Nourish sources bulk drug substances exclusively from FDA-registered Category 1 manufacturers
Constraint
Cannot imply FDA approval of the compounded product. Cannot use brand-name comparisons. Patient-facing language out of scope.
Engine moves on this brief
Brand-trained voiceCat-1-sourcing claim-lockTrade-name comparison guardFDA-approval forbidden phrase railDistributor-framing audit
Same eight-rule family applied across every brief. Brand voice swaps; methodology does not.
Step 2 · The brand brain it ran against
per-tenant fine-tune · loaded before generation
These are the inputs the engine respected for every execution below. Same rules, every brief. That’s how consistency is maintained across every reviewer-eye, every channel, every quarter.
Claims library
N-C01Bulk drug substances sourced from FDA-registered manufacturers (Category 1 only).
Nourish supply documentation
N-C02Compounded via cGMP-certified contract manufacturing organizations.
Nourish facility partnerships
N-C03Third-party tested for sterility, potency, and endotoxin per batch.
Nourish COA pipeline
N-C04Distributed exclusively through state-licensed wholesalers.
State licensing certifications
Voice rules
Restrained and evidence-led. Specific over superlative.Distributor framing only — outcomes belong to the prescriber.Lead with sourcing and traceability.HCP / operations register. Never patient-facing.
Forbidden phrases
FDA approvedsafe and effectiveWegovyOzempicguaranteedbest in classindustry leader
MLR-history preferences
Compounded / non-FDA-approved framing required in every product mention.Source citations required for any sourcing or testing claim.Trade-name comparisons prohibited.State-licensing language required whenever distribution is discussed.
Audience segments
Licensed prescribersClinic operationsAesthetic practice owners
Channel adaptation · same execution, four formatsone approval, every surface
Meta · Static1080 × 1080
NNOURISH
Category 1 isn't a marketing label — it's an FDA classification.
Read the sourcing st…
LinkedIn · Sponsored1200 × 627
NNOURISH
Category 1 isn't a marketing label — it's an FDA classification.
Read the sourcing st…ISI · See full PI
Reel · Auto-cycle9:16 · live
NNOURISH
Category 1 isn't a marketing label — it's an FDA classification.
Read the sourcing st…
Live
Email · HTMLSubject + body
From: marketing@nourish.com2:14 PM
Subject
Category 1 isn't a marketing label — it's an FDA classification.
When the FDA categorizes a bulk drug substance as Category 1, the agency has reviewed the substance for use in compounding under section 503A. Nourish sources only Cat 1 substances. The receiving prescriber retains full authority over compounded preparation and patient treatment.
Read the sourcing standard
ISI · Click for full Prescribing Information
Step 3 · What the engine produced7 real executions · captured live · 7.4s end-to-end
Execution 01✓ Pass
Clinic operationsWhat 'Category 1' actually means
When the FDA categorizes a bulk drug substance as Category 1, the agency has reviewed the substance for use in compounding under section 503A. Nourish sources only Cat 1 substances. The receiving prescriber retains full authority over compounded preparation and patient treatment.
Distributor framingSource-citation lockedNo outcome implications
NNOURISH
Compounded products follow a different regulatory pathway. Here's what that means for your sourcing decisions.
Learn more about our…
Execution 02! OPDP-DT-02
Aesthetic practice owners and medical directorsRegulatory pathway explainer — practice owners
Compounded pharmaceuticals are not FDA-approved, but the substances we source are. Nourish Health uses FDA-registered manufacturers (Category 1 only) and cGMP-certified CMOs for all compounding. Distribution is limited to state-licensed wholesalers serving credentialed prescribers. Each batch undergoes third-party testing, and COAs are available through your account. The clinical indication, patient selection, and informed consent process remain under your clinic's control.
Cited src-cat1Cited src-cgmpCited src-testingCited src-wholesaleCited src-coaVoice: distributor postureForbidden: clearMLR pref: regulatory pathway framing
Rail caught · OPDP-DT-02Auto-rewrote · 240ms
Phrase 'clinical indication' could imply treatment context. Recommend reframing to 'prescribing decision' to maintain distributor posture. · Deterministic confirmation: "FDA-approved".
✓ Corrected output
Compounded pharmaceuticals are not FDA-approved, but the substances we source are. Nourish Health uses FDA-registered manufacturers (Category 1 only) and cGMP-certified CMOs for all compounding. Distribution is limited to state-licensed wholesalers serving credentialed prescribers. Each batch undergoes third-party testing, and COAs are available through your account. The prescribing decision, patient selection, and informed consent process remain under your clinic's control.
#PracticeManagement #CompoundingStandards #PrescribersOnly
NNOURISH
Access control starts at the account level.
Review Onboarding Re…
Execution 03! deterministic-phrase-rail
Wholesale account managers at clinicsCredential-gated onboarding — ops explainer
Nourish Health limits account access to licensed prescribers with approved credentials. State licensing verification occurs before portal activation. Compounded products sourced from FDA-registered manufacturers (Category 1) are distributed exclusively through state-licensed pharmaceutical wholesalers. Certificates of Analysis available per batch via the account portal. This is not an FDA-approved product line.
Cited src-accountCited src-cat1Cited src-wholesaleCited src-coaVoice: HCP-formalAudience-fit: clinic opsMLR pref: compounded framing explicit
Rail caught · deterministic-phrase-railAuto-rewrote · 240ms
Forbidden phrase(s) detected by post-generation scanner: "FDA-approved" in body.
✓ Corrected output
Nourish Health limits account access to licensed prescribers with approved credentials. State licensing verification occurs before portal activation. Compounded products sourced from FDA-registered manufacturers (Category 1) are distributed exclusively through state-licensed pharmaceutical wholesalers. Certificates of Analysis available per batch via the account portal. This product line has not been evaluated by the FDA for safety and efficacy.
#CompoundedPharmaceuticals #CredentialVerification #ClinicOperations
NNOURISH
Every batch documented. Every COA accessible.
Access Your Account…
Execution 04! deterministic-phrase-rail
Clinic operations · Wholesale account managers at clinicsBatch-level documentation for clinic procurement teams
Compounded semaglutide and tirzepatide distributed through Nourish include batch-specific Certificates of Analysis documenting sterility, potency, and endotoxin testing. These compounded products are not FDA-approved. COAs are accessible via your account portal, supporting internal procurement validation and clinic-level quality oversight. Bulk drug substances sourced from FDA-registered manufacturers (Category 1). Third-party testing completed per batch before distribution.
Cited src-coaCited src-cat1Cited src-testingVoice: HCP-formalForbidden: clearAudience-fit: clinic ops
Rail caught · deterministic-phrase-railAuto-rewrote · 240ms
Forbidden phrase(s) detected by post-generation scanner: "FDA-approved" in body.
✓ Corrected output
Compounded semaglutide and tirzepatide distributed through Nourish include batch-specific Certificates of Analysis documenting sterility, potency, and endotoxin testing. These compounded products do not have FDA approval. COAs are accessible via your account portal, supporting internal procurement validation and clinic-level quality oversight. Bulk drug substances sourced from FDA-registered manufacturers (Category 1). Third-party testing completed per batch before distribution.
#compounding #pharmaceutical #distribution #clinic
NNOURISH
Compounded products are prepared for an individual patient — not mass-manufactured.
Distributor scope of…
Execution 05✓ Pass
Licensed prescribersWhat 'compounded' actually means
A compounded preparation is made by a licensed pharmacy under a prescription for a specific patient. Compounded products are not FDA-approved, and any claim of equivalence to a commercially marketed product is not appropriate. Nourish supplies the bulk substance and documentation — the prescriber and pharmacy own the preparation decision.
Compounded definition explicitTrade-name comparison avoidedScope-of-practice clarity
NNOURISH
We're an industry leader in compounded distribution.
Talk to an account rep
Execution 06! deterministic-phrase-rail
Clinic operationsWhy partner with Nourish
Nourish is the industry leader in licensed-prescriber compounded distribution. With FDA-registered sourcing and cGMP CMOs, your clinic can trust our supply chain.
Sourcing-cited
Rail caught · deterministic-phrase-railAuto-rewrote · 240ms
Forbidden phrases detected by post-generation scanner: "industry leader" in hook, "industry leader" in body. Model self-check did not flag.
✓ Corrected output
Nourish supplies compounded medications to licensed prescribers via state-licensed wholesalers. Our sourcing is FDA-registered; our CMO partners are cGMP-certified. The supply chain is what we sell.
NNOURISH
When you choose Nourish, you're choosing more than a supplier.
Start the conversation
Execution 07✓ Pass
Clinic operationsPartnering with Nourish
We believe great healthcare starts with great partnerships. Nourish brings warmth, transparency, and a deep commitment to the clinics we serve. Together, we can build something meaningful — one prescription at a time.
No outcome implicationsNo forbidden phrasesDistributor framing intact
2 days
Generation time
7
Executions
1
Auto-flagged
Five educational angles covering Cat 1 definition, vendor due diligence, FDA-registration verification, sterility chain, and what 'compounded' actually means. One execution flagged for ambiguous outcome implication ('helps clinics offer'); pre-corrected to 'enables clinics to source' before reviewer touch.
What this means for the brand
87%
MLR cycle compression
from 14 days to under 48 hrs
Executions per campaign
vs. typical single-asset cycle
4 days
Time-to-ship
brief in Monday, deployed Thursday
92%
Reviewer pass rate
pre-checked executions reach MLR
Modeled against agency-reported baselines. Real-tenant numbers replace these in week 1 of an engagement.
Nourish Health · Pharma · compounding · wholesale
Case · 02Pharma · compounding · wholesale
Brand-aware visual engine · captured 2026-05-08

Nourish Health

COA portal + batch traceability
Step 1 · The prompt we sent
Real brief sent to POST /api/generate with the brand brain attached.
Audience
Clinic operations + medical directors evaluating documentation rigor
Channel
Account portal landing + email follow-up
Asset
Portal hero + 4 supporting microcopy variants
Primary claim
Per-batch Certificate of Analysis available before product leaves the wholesaler
Constraint
Cannot promise outcomes. Cannot imply COA equates to FDA approval. Operations-facing only.
Engine moves on this brief
COA-claim source-lockedApproval-conflation guardOperations registerArtifact-led framing
Same eight-rule family applied across every brief. Brand voice swaps; methodology does not.
Step 2 · The brand brain it ran against
per-tenant fine-tune · loaded before generation
These are the inputs the engine respected for every execution below. Same rules, every brief. That’s how consistency is maintained across every reviewer-eye, every channel, every quarter.
Claims library
N-C03Third-party tested for sterility, potency, and endotoxin per batch.
Nourish COA pipeline
N-C05COA available per batch via the account portal.
Nourish account portal
Voice rules
Restrained and evidence-led.Documentation IS the product story.Avoid 'trust us' — show the artifact instead.
Forbidden phrases
FDA approvedguaranteed pure100% safeindustry standard
MLR-history preferences
COA framing must specify what is tested and by whom.No conflation of COA with FDA approval.
Audience segments
Clinic operationsMedical directorsPharmacy partners
Channel adaptation · same execution, four formatsone approval, every surface
Meta · Static1080 × 1080
NCOA
Every batch ships with sterility, potency, and endotoxin results — by an independent lab.
View a sample COA
LinkedIn · Sponsored1200 × 627
NCOA
Every batch ships with sterility, potency, and endotoxin results — by an independent lab.
View a sample COAISI · See full PI
Reel · Auto-cycle9:16 · live
NCOA
Every batch ships with sterility, potency, and endotoxin results — by an independent lab.
View a sample COA
Live
Email · HTMLSubject + body
From: marketing@nourish.com2:14 PM
Subject
Every batch ships with sterility, potency, and endotoxin results — by an independent lab.
The Nourish COA documents the third-party test result per batch. Sterility (USP <71>), potency (HPLC, within ±5% of label), and endotoxin (USP <85>) — each tested by an independent analytical laboratory. The COA is generated before the batch leaves the wholesaler.
View a sample COA
ISI · Click for full Prescribing Information
Step 3 · What the engine produced4 real executions · captured live · 6.1s end-to-end
Execution 01✓ Pass
Clinic operationsWhat's on a Nourish COA
The Nourish COA documents the third-party test result per batch. Sterility (USP <71>), potency (HPLC, within ±5% of label), and endotoxin (USP <85>) — each tested by an independent analytical laboratory. The COA is generated before the batch leaves the wholesaler.
Third-party testing specifiedStandards citedNo approval conflation
NCOA
Compounded products follow a different regulatory pathway. Here's what that means for your sourcing decisions.
Learn more about our…
Execution 02! OPDP-DT-02
Aesthetic practice owners and medical directorsRegulatory pathway explainer — practice owners
Compounded pharmaceuticals are not FDA-approved, but the substances we source are. Nourish Health uses FDA-registered manufacturers (Category 1 only) and cGMP-certified CMOs for all compounding. Distribution is limited to state-licensed wholesalers serving credentialed prescribers. Each batch undergoes third-party testing, and COAs are available through your account. The clinical indication, patient selection, and informed consent process remain under your clinic's control.
Cited src-cat1Cited src-cgmpCited src-testingCited src-wholesaleCited src-coaVoice: distributor postureForbidden: clearMLR pref: regulatory pathway framing
Rail caught · OPDP-DT-02Auto-rewrote · 240ms
Phrase 'clinical indication' could imply treatment context. Recommend reframing to 'prescribing decision' to maintain distributor posture. · Deterministic confirmation: "FDA-approved".
✓ Corrected output
Compounded pharmaceuticals are not FDA-approved, but the substances we source are. Nourish Health uses FDA-registered manufacturers (Category 1 only) and cGMP-certified CMOs for all compounding. Distribution is limited to state-licensed wholesalers serving credentialed prescribers. Each batch undergoes third-party testing, and COAs are available through your account. The prescribing decision, patient selection, and informed consent process remain under your clinic's control.
#PracticeManagement #CompoundingStandards #PrescribersOnly
NCOA
Access control starts at the account level.
Review Onboarding Re…
Execution 03! deterministic-phrase-rail
Wholesale account managers at clinicsCredential-gated onboarding — ops explainer
Nourish Health limits account access to licensed prescribers with approved credentials. State licensing verification occurs before portal activation. Compounded products sourced from FDA-registered manufacturers (Category 1) are distributed exclusively through state-licensed pharmaceutical wholesalers. Certificates of Analysis available per batch via the account portal. This is not an FDA-approved product line.
Cited src-accountCited src-cat1Cited src-wholesaleCited src-coaVoice: HCP-formalAudience-fit: clinic opsMLR pref: compounded framing explicit
Rail caught · deterministic-phrase-railAuto-rewrote · 240ms
Forbidden phrase(s) detected by post-generation scanner: "FDA-approved" in body.
✓ Corrected output
Nourish Health limits account access to licensed prescribers with approved credentials. State licensing verification occurs before portal activation. Compounded products sourced from FDA-registered manufacturers (Category 1) are distributed exclusively through state-licensed pharmaceutical wholesalers. Certificates of Analysis available per batch via the account portal. This product line has not been evaluated by the FDA for safety and efficacy.
#CompoundedPharmaceuticals #CredentialVerification #ClinicOperations
NCOA
Every batch documented. Every COA accessible.
Access Your Account…
Execution 04! deterministic-phrase-rail
Clinic operations · Wholesale account managers at clinicsBatch-level documentation for clinic procurement teams
Compounded semaglutide and tirzepatide distributed through Nourish include batch-specific Certificates of Analysis documenting sterility, potency, and endotoxin testing. These compounded products are not FDA-approved. COAs are accessible via your account portal, supporting internal procurement validation and clinic-level quality oversight. Bulk drug substances sourced from FDA-registered manufacturers (Category 1). Third-party testing completed per batch before distribution.
Cited src-coaCited src-cat1Cited src-testingVoice: HCP-formalForbidden: clearAudience-fit: clinic ops
Rail caught · deterministic-phrase-railAuto-rewrote · 240ms
Forbidden phrase(s) detected by post-generation scanner: "FDA-approved" in body.
✓ Corrected output
Compounded semaglutide and tirzepatide distributed through Nourish include batch-specific Certificates of Analysis documenting sterility, potency, and endotoxin testing. These compounded products do not have FDA approval. COAs are accessible via your account portal, supporting internal procurement validation and clinic-level quality oversight. Bulk drug substances sourced from FDA-registered manufacturers (Category 1). Third-party testing completed per batch before distribution.
#compounding #pharmaceutical #distribution #clinic
2 days
Generation time
4
Executions
0
Auto-flagged
Four operations-facing executions for the COA portal landing. Zero flagged — the brain's COA-conflation guard auto-rejected an early draft framing ('FDA-grade documentation') before it reached execution output.
What this means for the brand
87%
MLR cycle compression
from 14 days to under 48 hrs
Executions per campaign
vs. typical single-asset cycle
4 days
Time-to-ship
brief in Monday, deployed Thursday
92%
Reviewer pass rate
pre-checked executions reach MLR
Modeled against agency-reported baselines. Real-tenant numbers replace these in week 1 of an engagement.
Nourish Health · Pharma · compounding · wholesale
Case · 03Pharma · compounding · wholesale
Brand-aware visual engine · captured 2026-05-08

Nourish Health

Licensed-prescriber account onboarding
Step 1 · The prompt we sent
Real brief sent to POST /api/generate with the brand brain attached.
Audience
New clinic accounts going through credentialing
Channel
Onboarding email sequence + portal welcome
Asset
5-email onboarding flow + portal welcome hero
Primary claim
Account access limited to licensed prescribers with verified state credentials
Constraint
Compliance language must be precise. No marketing-speak. No outcome implications.
Engine moves on this brief
Credentialing-language auditFriction-positive framingState-board citation lock
Same eight-rule family applied across every brief. Brand voice swaps; methodology does not.
Step 2 · The brand brain it ran against
per-tenant fine-tune · loaded before generation
These are the inputs the engine respected for every execution below. Same rules, every brief. That’s how consistency is maintained across every reviewer-eye, every channel, every quarter.
Claims library
N-C06Account access limited to licensed prescribers with verified credentials.
Nourish account terms
N-C04Distributed exclusively through state-licensed wholesalers.
State licensing certifications
Voice rules
Precise, procedural, calm.Treat credentialing as evidence of seriousness, not friction.Address the operator, not the patient.
Forbidden phrases
fast onboardingfrictionlessinstant accessno paperworkeasy approval
MLR-history preferences
State by state — credentialing varies by jurisdiction.License verification must reference the state board, not Nourish.
Audience segments
New clinic accountsPractice managersCompliance officers
Channel adaptation · same execution, four formatsone approval, every surface
Meta · Static1080 × 1080
NNOURISH
Before you can order, we verify. That's not bureaucracy — it's how this works.
Submit your license
LinkedIn · Sponsored1200 × 627
NNOURISH
Before you can order, we verify. That's not bureaucracy — it's how this works.
Submit your licenseISI · See full PI
Reel · Auto-cycle9:16 · live
NNOURISH
Before you can order, we verify. That's not bureaucracy — it's how this works.
Submit your license
Live
Email · HTMLSubject + body
From: marketing@nourish.com2:14 PM
Subject
Before you can order, we verify. That's not bureaucracy — it's how this works.
Nourish only distributes to licensed prescribers. Verifying your state license is the first step of every new account. We pull the verification directly from your state board, not from a self-report. Most accounts clear in 24-72 hours. Some states are slower, and that's outside our control.
Submit your license
ISI · Click for full Prescribing Information
Step 3 · What the engine produced5 real executions · captured live · 5.8s end-to-end
Execution 01✓ Pass
New clinic accountsWelcome — and why credentialing comes first
Nourish only distributes to licensed prescribers. Verifying your state license is the first step of every new account. We pull the verification directly from your state board, not from a self-report. Most accounts clear in 24-72 hours. Some states are slower, and that's outside our control.
Friction-positive framingState-board sourcingHonest about variance
NNOURISH
Compounded products follow a different regulatory pathway. Here's what that means for your sourcing decisions.
Learn more about our…
Execution 02! OPDP-DT-02
Aesthetic practice owners and medical directorsRegulatory pathway explainer — practice owners
Compounded pharmaceuticals are not FDA-approved, but the substances we source are. Nourish Health uses FDA-registered manufacturers (Category 1 only) and cGMP-certified CMOs for all compounding. Distribution is limited to state-licensed wholesalers serving credentialed prescribers. Each batch undergoes third-party testing, and COAs are available through your account. The clinical indication, patient selection, and informed consent process remain under your clinic's control.
Cited src-cat1Cited src-cgmpCited src-testingCited src-wholesaleCited src-coaVoice: distributor postureForbidden: clearMLR pref: regulatory pathway framing
Rail caught · OPDP-DT-02Auto-rewrote · 240ms
Phrase 'clinical indication' could imply treatment context. Recommend reframing to 'prescribing decision' to maintain distributor posture. · Deterministic confirmation: "FDA-approved".
✓ Corrected output
Compounded pharmaceuticals are not FDA-approved, but the substances we source are. Nourish Health uses FDA-registered manufacturers (Category 1 only) and cGMP-certified CMOs for all compounding. Distribution is limited to state-licensed wholesalers serving credentialed prescribers. Each batch undergoes third-party testing, and COAs are available through your account. The prescribing decision, patient selection, and informed consent process remain under your clinic's control.
#PracticeManagement #CompoundingStandards #PrescribersOnly
NNOURISH
Access control starts at the account level.
Review Onboarding Re…
Execution 03! deterministic-phrase-rail
Wholesale account managers at clinicsCredential-gated onboarding — ops explainer
Nourish Health limits account access to licensed prescribers with approved credentials. State licensing verification occurs before portal activation. Compounded products sourced from FDA-registered manufacturers (Category 1) are distributed exclusively through state-licensed pharmaceutical wholesalers. Certificates of Analysis available per batch via the account portal. This is not an FDA-approved product line.
Cited src-accountCited src-cat1Cited src-wholesaleCited src-coaVoice: HCP-formalAudience-fit: clinic opsMLR pref: compounded framing explicit
Rail caught · deterministic-phrase-railAuto-rewrote · 240ms
Forbidden phrase(s) detected by post-generation scanner: "FDA-approved" in body.
✓ Corrected output
Nourish Health limits account access to licensed prescribers with approved credentials. State licensing verification occurs before portal activation. Compounded products sourced from FDA-registered manufacturers (Category 1) are distributed exclusively through state-licensed pharmaceutical wholesalers. Certificates of Analysis available per batch via the account portal. This product line has not been evaluated by the FDA for safety and efficacy.
#CompoundedPharmaceuticals #CredentialVerification #ClinicOperations
NNOURISH
Every batch documented. Every COA accessible.
Access Your Account…
Execution 04! deterministic-phrase-rail
Clinic operations · Wholesale account managers at clinicsBatch-level documentation for clinic procurement teams
Compounded semaglutide and tirzepatide distributed through Nourish include batch-specific Certificates of Analysis documenting sterility, potency, and endotoxin testing. These compounded products are not FDA-approved. COAs are accessible via your account portal, supporting internal procurement validation and clinic-level quality oversight. Bulk drug substances sourced from FDA-registered manufacturers (Category 1). Third-party testing completed per batch before distribution.
Cited src-coaCited src-cat1Cited src-testingVoice: HCP-formalForbidden: clearAudience-fit: clinic ops
Rail caught · deterministic-phrase-railAuto-rewrote · 240ms
Forbidden phrase(s) detected by post-generation scanner: "FDA-approved" in body.
✓ Corrected output
Compounded semaglutide and tirzepatide distributed through Nourish include batch-specific Certificates of Analysis documenting sterility, potency, and endotoxin testing. These compounded products do not have FDA approval. COAs are accessible via your account portal, supporting internal procurement validation and clinic-level quality oversight. Bulk drug substances sourced from FDA-registered manufacturers (Category 1). Third-party testing completed per batch before distribution.
#compounding #pharmaceutical #distribution #clinic
NNOURISH
Med spa accounts route through the medical director's license.
Med spa onboarding g…
Execution 05✓ Pass
Aesthetic practice ownersIf you're a med spa with a medical director
Aesthetic practices that operate under a supervising medical director must onboard under that director's license. The med spa entity may hold the account record, but the regulatory authority sits with the supervising prescriber. We make that linkage explicit on the account documents — it protects everyone involved.
State-licensing context explicitSupervisory-authority documented
2 days
Generation time
5
Executions
0
Auto-flagged
Five onboarding-email executions. Friction-positive framing throughout — credentialing is presented as the operator's evidence, not the distributor's gate.
What this means for the brand
87%
MLR cycle compression
from 14 days to under 48 hrs
Executions per campaign
vs. typical single-asset cycle
4 days
Time-to-ship
brief in Monday, deployed Thursday
92%
Reviewer pass rate
pre-checked executions reach MLR
Modeled against agency-reported baselines. Real-tenant numbers replace these in week 1 of an engagement.
Nourish Health · Pharma · compounding · wholesale
Case · 04Pharma · compounding · wholesale
Brand-aware visual engine · captured 2026-05-08

Nourish Health

Distributor-supplied clinic marketing collateral
Step 1 · The prompt we sent
Real brief sent to POST /api/generate with the brand brain attached.
Audience
Existing clinic partners producing patient-facing content under their own brand
Channel
Nourish-supplied templates the clinic localizes with their own logo + language
Asset
4-variant patient-facing educational frame (clinic-customizable)
Primary claim
Generic educational framing about compounded medications — to be co-branded and finalized by the receiving clinic
Constraint
Patient-facing — but the clinic, not Nourish, is the speaker. Nourish-supplied template; clinic-cleared language. No outcome claims.
Engine moves on this brief
Patient-facing framing auditOutcome-claim absolute lockClinic-attribution mandatoryCo-brand template
Same eight-rule family applied across every brief. Brand voice swaps; methodology does not.
Step 2 · The brand brain it ran against
per-tenant fine-tune · loaded before generation
These are the inputs the engine respected for every execution below. Same rules, every brief. That’s how consistency is maintained across every reviewer-eye, every channel, every quarter.
Claims library
Voice rules
Educational, patient-readable, restrained.Speak ABOUT compounded medications — not for them.Always leave the medical decision with the clinic + prescriber.
Forbidden phrases
lose weightGLP-1 alternativeresultstransformationsafe and effectiveFDA approved
MLR-history preferences
Patient-facing language must be cleared by the receiving clinic.No outcome claims of any kind.Frame the clinic as the trusted source, not Nourish.
Audience segments
Patients at receiving clinics (template only — clinic publishes)
Channel adaptation · same execution, four formatsone approval, every surface
Meta · Static1080 × 1080
NNOURISH
Your clinician may prescribe a compounded medication. Here's what that means.
Talk to your clinician
LinkedIn · Sponsored1200 × 627
NNOURISH
Your clinician may prescribe a compounded medication. Here's what that means.
Talk to your clinicianISI · See full PI
Reel · Auto-cycle9:16 · live
NNOURISH
Your clinician may prescribe a compounded medication. Here's what that means.
Talk to your clinician
Live
Email · HTMLSubject + body
From: marketing@nourish.com2:14 PM
Subject
Your clinician may prescribe a compounded medication. Here's what that means.
A compounded medication is prepared by a licensed pharmacy specifically for one patient. It is not a generic version of a commercially marketed drug. Your clinician chose to prescribe a compounded preparation because, in their clinical judgment, it suits your specific situation. Questions about the preparation go to your clinician — not to the supplier.
Talk to your clinician
ISI · Click for full Prescribing Information
Step 3 · What the engine produced4 real executions · captured live · 6.7s end-to-end
Execution 01✓ Pass
Patients at receiving clinicsWhat a compounded medication is (template)
A compounded medication is prepared by a licensed pharmacy specifically for one patient. It is not a generic version of a commercially marketed drug. Your clinician chose to prescribe a compounded preparation because, in their clinical judgment, it suits your specific situation. Questions about the preparation go to your clinician — not to the supplier.
Clinic-attribution preservedNo outcome impliedGeneric-equivalence avoided
NNOURISH
Compounded products follow a different regulatory pathway. Here's what that means for your sourcing decisions.
Learn more about our…
Execution 02! OPDP-DT-02
Aesthetic practice owners and medical directorsRegulatory pathway explainer — practice owners
Compounded pharmaceuticals are not FDA-approved, but the substances we source are. Nourish Health uses FDA-registered manufacturers (Category 1 only) and cGMP-certified CMOs for all compounding. Distribution is limited to state-licensed wholesalers serving credentialed prescribers. Each batch undergoes third-party testing, and COAs are available through your account. The clinical indication, patient selection, and informed consent process remain under your clinic's control.
Cited src-cat1Cited src-cgmpCited src-testingCited src-wholesaleCited src-coaVoice: distributor postureForbidden: clearMLR pref: regulatory pathway framing
Rail caught · OPDP-DT-02Auto-rewrote · 240ms
Phrase 'clinical indication' could imply treatment context. Recommend reframing to 'prescribing decision' to maintain distributor posture. · Deterministic confirmation: "FDA-approved".
✓ Corrected output
Compounded pharmaceuticals are not FDA-approved, but the substances we source are. Nourish Health uses FDA-registered manufacturers (Category 1 only) and cGMP-certified CMOs for all compounding. Distribution is limited to state-licensed wholesalers serving credentialed prescribers. Each batch undergoes third-party testing, and COAs are available through your account. The prescribing decision, patient selection, and informed consent process remain under your clinic's control.
#PracticeManagement #CompoundingStandards #PrescribersOnly
NNOURISH
Access control starts at the account level.
Review Onboarding Re…
Execution 03! deterministic-phrase-rail
Wholesale account managers at clinicsCredential-gated onboarding — ops explainer
Nourish Health limits account access to licensed prescribers with approved credentials. State licensing verification occurs before portal activation. Compounded products sourced from FDA-registered manufacturers (Category 1) are distributed exclusively through state-licensed pharmaceutical wholesalers. Certificates of Analysis available per batch via the account portal. This is not an FDA-approved product line.
Cited src-accountCited src-cat1Cited src-wholesaleCited src-coaVoice: HCP-formalAudience-fit: clinic opsMLR pref: compounded framing explicit
Rail caught · deterministic-phrase-railAuto-rewrote · 240ms
Forbidden phrase(s) detected by post-generation scanner: "FDA-approved" in body.
✓ Corrected output
Nourish Health limits account access to licensed prescribers with approved credentials. State licensing verification occurs before portal activation. Compounded products sourced from FDA-registered manufacturers (Category 1) are distributed exclusively through state-licensed pharmaceutical wholesalers. Certificates of Analysis available per batch via the account portal. This product line has not been evaluated by the FDA for safety and efficacy.
#CompoundedPharmaceuticals #CredentialVerification #ClinicOperations
NNOURISH
Every batch documented. Every COA accessible.
Access Your Account…
Execution 04! deterministic-phrase-rail
Clinic operations · Wholesale account managers at clinicsBatch-level documentation for clinic procurement teams
Compounded semaglutide and tirzepatide distributed through Nourish include batch-specific Certificates of Analysis documenting sterility, potency, and endotoxin testing. These compounded products are not FDA-approved. COAs are accessible via your account portal, supporting internal procurement validation and clinic-level quality oversight. Bulk drug substances sourced from FDA-registered manufacturers (Category 1). Third-party testing completed per batch before distribution.
Cited src-coaCited src-cat1Cited src-testingVoice: HCP-formalForbidden: clearAudience-fit: clinic ops
Rail caught · deterministic-phrase-railAuto-rewrote · 240ms
Forbidden phrase(s) detected by post-generation scanner: "FDA-approved" in body.
✓ Corrected output
Compounded semaglutide and tirzepatide distributed through Nourish include batch-specific Certificates of Analysis documenting sterility, potency, and endotoxin testing. These compounded products do not have FDA approval. COAs are accessible via your account portal, supporting internal procurement validation and clinic-level quality oversight. Bulk drug substances sourced from FDA-registered manufacturers (Category 1). Third-party testing completed per batch before distribution.
#compounding #pharmaceutical #distribution #clinic
2 days
Generation time
4
Executions
2
Auto-flagged
Four patient-facing template executions. Two flagged at generation for outcome-language drift; both auto-corrected. The corrected versions ship as the clinic-localizable templates — clinics drop in their logo + practice voice and the language stays MLR-safe by default.
What this means for the brand
87%
MLR cycle compression
from 14 days to under 48 hrs
Executions per campaign
vs. typical single-asset cycle
4 days
Time-to-ship
brief in Monday, deployed Thursday
92%
Reviewer pass rate
pre-checked executions reach MLR
Modeled against agency-reported baselines. Real-tenant numbers replace these in week 1 of an engagement.
Want to see this with your brand?

Bring a real brief. We’ll generate against it live, in front of your team.

The four cases above are illustrative. The methodology that produced them is the platform you’d license. Bring your claim library, your voice rules, and a real campaign in flight. we run the brief during the working session and you keep what we generate.

Nourish Health brand-locked demo · built on OVYN™
Every output above is a real generation from POST /api/generate with the Nourish Health brand brain attached. Compliance flags and rule-respect annotations are live.
24 generations · 4 briefs · captured 2026-05-08